NLS Pharmaceutics Ltd - Warrants (25/09/2025) Accounts Payable

As of the most recent data (June 2025), NLSPW shows a accounts payable of $1M. That compares with $4.6M in the prior-year period — down 77.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NLSPW's accounts payable is now $1M (was $4.6M) — a 77.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is outperforming or lagging.

Tracking NLSPW's accounts payable over time shows whether NLS Pharmaceutics Ltd - Warrants (25/09/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $1M That compares with $4.6M in the prior-year period — down 77.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1M) with ownership activity and broader fundamentals.

NLS Pharmaceutics Ltd - Warrants (25/09/2025)'s accounts payable is $1M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.